References
Nayak B, Dogra PN, Naswa N, Kumar R. Diuretic 18 F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging. 2013;40:386–93.
Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–66.
Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S–50S.
Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.
Author information
Authors and Affiliations
Corresponding author
Additional information
Charline Lasnon and Elodie Coquan equally contributed to this work.
Rights and permissions
About this article
Cite this article
Coquan, E., Lasnon, C., Joly, F. et al. Diuretic 18 F-FDG PET/CT for therapy monitoring in urothelial bladder cancer. Eur J Nucl Med Mol Imaging 41, 1818–1819 (2014). https://doi.org/10.1007/s00259-014-2800-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-014-2800-0